Home > Press > Heritage Worldwide Increases Manufacturing Capacity to Meet Growing Product Demand
Abstract:
Company Plans to Enlarge Manufacturing Facility, Increase Capacity Further
Heritage Worldwide Increases Manufacturing Capacity to Meet Growing Product Demand
LA SEYNE-SUR-MER, France | Posted on March 27th, 2007
Heritage Worldwide, Inc. (OTC Bulletin Board: HWWI), a top provider of pre-filled
breast implants worldwide, announced that in order to meet increased demand
worldwide for its breast implants, it is expanding its manufacturing
capacity to accommodate the 38 percent increase in demand projected for
fiscal 2007 -- to 145,000 units, from 105,000 units for fiscal 2006.
Jean-Claude Mas, Chairman and CEO of Heritage Worldwide, commented,
"The progress we've made since March 2003 has been consistently on target
and more than satisfactory. Our recent success is due primarily to the
increase in the number of countries where we've been marketing our implants
(new sale authorizations). In particular, we made substantial headway into
Brazil and Argentina. We continue to do well in Europe, and have made
significant inroads into Australia and Asia. We are very pleased to report
our substantial growth and look forward to increasing our capacity even
further in 2008 and beyond."
Heritage Worldwide sells its products directly in France and Spain, and
through distributors in 63 other countries. Its focus is on Asia and the
Latin American markets, which the Company believes are growing very
rapidly.
The Company plans to expand its clean room to increase production
levels. This expansion will increase manufacturing capacity 275 percent --
from 160,000 units to 600,000 units per year, enabling Heritage Worldwide
to focus on its new products.
"Each product in our pipeline is truly innovative and already in
various stages of development," added Mr. Mas. "Moreover, excluding breast
implants which are Class III, our other pipeline products are Class II B,
so each will be able to receive a CE mark more quickly, generally
speaking."
During fiscal 2006, Heritage Worldwide announced new product
initiatives as follows:
* a breast implant filled with a specially engineered hydrogel that
mimics the physical properties of silicone gel, which will be a
substitute for silicone gel,
* an innovative dermal-filler, for the elimination of wrinkles and
creases,
* an anatomical breast implant,
* silicone-rubber body support implants (testicular, buttock and calf),
expected towards the end of 2007, and
* perhaps its most innovative product, a breast implant that uses
nanotechnology to coat and totally seal the implant with titanium,
expected during the second half of 2009.
####
About Heritage Worldwide, Inc.
The Company is incorporated in the State of Delaware. The Company's
subsidiaries develop, manufacture, and market breast and other body
implants and body support products worldwide. One of the Company's
subsidiaries, PIP France, maintains its production facility in the Toulon
metropolitan area in Southern France, with a distribution facility in
Spain.
Cautionary Language Concerning Forward-looking Statements
All statements included in this release, other than statements or
characterizations of historical fact, are forward-looking statements. These
forward-looking statements are based on current expectations, estimates,
projections about our industry, management's beliefs and certain
assumptions made by us. Forward-looking statements can often be identified
by words such as "anticipates," "expects," "intends," "plans," "predicts,"
"believes," "seeks," "estimates," "may," "will," "should," "would,"
"could," "potential," "continue," and similar expressions and variations,
or negatives of these words. In addition, any statements that refer to
expectations, projections, or other characterizations of future events or
circumstances, including any underlying assumptions, are forward-looking
statements. These forward looking-statements speak only as of the date
hereof and are based upon the information available to us at this time.
Such information is subject to change, and we will not necessarily inform
you of such changes. These statements are not guarantees of future results
and are subject to risks, uncertainties and assumptions that are difficult
to predict. Therefore, our actual results could differ materially and
adversely from those expressed in any forward-looking statement as a result
of various factors.
Important factors that may cause such a difference for Heritage
Worldwide include, but are not limited to competitive pressures and other
factors such as the introduction or regulatory approval of new products by
our competitors and pricing of competing products and the resulting effects
on sales and pricing of our products, disruptions or other problems with
our sources of supply, significant product liability or other claims,
difficulties with new product development and market acceptance, patent
conflicts, product recalls, United States Food and Drug Administration
delay in approval or rejection of new and existing products, changes in
governmental regulations, use of hazardous or environmentally sensitive
materials, our inability to implement new information technology systems,
and other events.
Our Annual Report on Form 10-KSB and other Securities and Exchange
Commission filings discuss the foregoing risks as well as other important
risk factors that could contribute to such differences or otherwise affect
our business, results of operations and financial condition. We undertake
no obligation to revise or update publicly any forward-looking statement
for any reason.
For more information, please click here
Contacts:
Claude Couty
Chief Financial Officer, Heritage Worldwide,Inc.,
+011-33-4-94-10-78-08
Copyright © PR Newswire Association LLC.
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
Nanomedicine
Nano-needles for cells May 25th, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Announcements
Nano-needles for cells May 25th, 2013
How do cold ions slide May 24th, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013
Human Interest/Art
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
Oh, Christmas tree, oh Christmas tree: A nano end for Christmas tree needles January 2nd, 2013
INIC Inks MoU to Apply Nanotechnology in Iran's Carpet Industry December 18th, 2012
IBN Welcomes Its First 9-Year-Old ‘Scientist’: IBN and Make-A-Wish Foundation Singapore Make Kidney Patient’s Dream Come True December 10th, 2012